Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo

被引:279
作者
Sun, YX
Schneider, A
Jung, Y
Wang, J
Dai, JL
Wang, JC
Cook, K
Osman, NI
Koh-Paige, AJ
Shim, H
Pienta, KJ
Keller, ET
McCauley, LK
Taichman, RS
机构
[1] Univ Michigan, Sch Dent, Dept Periodont Prevent Geriatr, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Undergrad Res Opportun Program, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA
[5] Emory Univ, Winship Canc Inst, Dept Hematol Oncol, Atlanta, GA 30322 USA
[6] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA
[7] Emory Univ, Sch Med, Div Internal Med & Urol, Atlanta, GA 30322 USA
[8] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA
关键词
metastasis; chemokine; marrow; prostate cancer; bone;
D O I
10.1359/JBMR.041109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To delineate the role of SDF-1 and CXCR4 in metastatic prostate cancer (CaP), positive correlations were established between SDF-1 levels and tumor metastasis. Neutralization of CXCR4 limited the number and the growth of intraosseous metastasis in vivo. Together, these in vivo metastasis data provide critical support that SDF-1/CXCR4 plays a role in skeletal metastasis.
引用
收藏
页码:318 / 329
页数:12
相关论文
共 49 条
[1]   The CXC chemokine, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis [J].
Addison, CL ;
Arenberg, DA ;
Morris, SB ;
Xue, YY ;
Burdick, MD ;
Mulligan, MS ;
Iannettoni, MD ;
Strieter, RM .
HUMAN GENE THERAPY, 2000, 11 (02) :247-261
[2]  
Aiuti A, 1999, EUR J IMMUNOL, V29, P1823, DOI 10.1002/(SICI)1521-4141(199906)29:06<1823::AID-IMMU1823>3.0.CO
[3]  
2-B
[4]   Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine [J].
Amara, A ;
Lorthioir, O ;
Valenzuela, A ;
Magerus, A ;
Thelen, M ;
Montes, M ;
Virelizier, JL ;
Delepierre, M ;
Baleux, F ;
Lortat-Jacob, H ;
Arenzana-Seisdedos, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23916-23925
[5]  
Bertolini F, 2002, CANCER RES, V62, P3106
[6]   Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs [J].
Blalock, WL ;
Weinstein-Oppenheimer, C ;
Chang, F ;
Hoyle, PE ;
Wang, XY ;
Algate, PA ;
Franklin, RA ;
Oberhaus, SM ;
Steelman, LS ;
McCubrey, JA .
LEUKEMIA, 1999, 13 (08) :1109-1166
[7]   Stromal factors involved in prostate carcinoma metastasis to bone [J].
Cooper, CR ;
Chay, CH ;
Gendernalik, JD ;
Lee, HL ;
Bhatia, J ;
Taichman, RS ;
McCauley, LK ;
Keller, ET ;
Pienta, KJ .
CANCER, 2003, 97 (03) :739-747
[8]   Chemokine receptor (CXCR4) mRNA-expressing leukocytes are increased in human renal allograft rejection [J].
Eitner, F ;
Cui, Y ;
Hudkins, KL ;
Alpers, CE .
TRANSPLANTATION, 1998, 66 (11) :1551-1557
[9]   A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma [J].
Geminder, H ;
Sagi-Assif, O ;
Goldberg, L ;
Meshel, T ;
Rechavi, G ;
Witz, IP ;
Ben-Baruch, A .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4747-4757
[10]  
Gerritsen ME, 2002, EXP NEPHROL, V10, P114